首页> 外国专利> REPERTOIRE OF ALLO-RESTRICTED PEPTIDE-SPECIFIC T CELL RECEPTOR SEQUENCES AND USE THEREOF

REPERTOIRE OF ALLO-RESTRICTED PEPTIDE-SPECIFIC T CELL RECEPTOR SEQUENCES AND USE THEREOF

机译:异源限制肽特异性T细胞受体序列库及其用途

摘要

#$%^&*AU2015230741B920170921.pdf#####Abstract: The present invention is directed to a kit-of-parts or composition containing nucleic acid sequences coding for high-avidity, allo-restricted TCR, wherein the TCR are independently directed against the tyrosinase antigen, the melan-A antigen and the survivin antigen. The invention is further directed to a kit-of-parts or composition containing at least three groups of transgenic lymphocytes transformed with vectors coding for TCR against said antigens. Furthermore, the present invention provides a pharmaceutical composition and its use in the treatment of diseases involving malignant cells expressing said tumor-associated antigens. The invention further relates to a nucleic acid molecule coding for a TCR that recognizes the survivin antigen, a TCR encoded thereby and a T cell expressing said TCR. Further, the invention discloses a vector, a cell and a pharmaceutical composition encoding/containing same and their use in the treatment of diseases involving malignant cells expressing survivin.
机译:#$%^&* AU2015230741B920170921.pdf #####抽象:本发明涉及含有核酸的试剂盒或组合物编码高亲和力,同素限制的TCR的序列,其中TCR独立针对酪氨酸酶抗原,黑色素A抗原和存活蛋白抗原。的本发明还涉及包含至少三组甲酸酯的试剂盒或组合物。用编码针对所述抗原的TCR的载体转化的转基因淋巴细胞。此外,本发明提供了药物组合物及其在药物治疗中的用途。治疗涉及表达所述肿瘤相关抗原的恶性细胞的疾病。本发明进一步涉及编码TCR的核酸分子,该TCR识别RNA。存活蛋白抗原,由其编码的TCR和表达所述TCR的T细胞。此外,本发明公开了编码/包含的载体,细胞和药物组合物它们及其在涉及表达survivin的恶性细胞的疾病的治疗中的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号